Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (940)	3/23/1999 6:51:00 PM
From: sim1	Respond to of 3202

Several articles in the April issue of the Red Herring. Briefing: Biotech Beyond the Genome Now that the human genome is nearly sequenced, biotech companies are putting the information to use. Contents The Postgenomic World New opportunities are emerging in cells, proteins and pharmacogenomics. Keep Your Genes On Jeremy Rifkin on the dangers of gene patenting. Gene Sequencing Explained. Double Fault Why investors have little interest in cloning. Fail Early and Prosper Spotfire's bioinformatics software gives researchers a shortcut for drug discovery. VC Whispers. Private Company Profiles. Public Company Profiles. Street Talk.